Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

[Effect of phenylhexyl isothiocyanate on drug-resistance to imatinib in K562/G01 cell line].

Wu RJ, Huang YQ, Ma XD.

Zhonghua Xue Ye Xue Za Zhi. 2013 Feb;34(2):149-52. Chinese.

PMID:
23611223
2.

[Establishment of an imatinib resistant cell line K562/G01 and its characterization].

Qi J, Peng H, Gu ZL, Liang ZQ, Yang CZ.

Zhonghua Xue Ye Xue Za Zhi. 2004 Jun;25(6):337-41. Chinese.

PMID:
15308010
3.

[Triptolide inhibits proliferation and induces apoptosis of imatinib resistant K562/G01 cells].

Wen SQ, Ma LM, Lu YJ, Bai B.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Oct;21(5):1148-52. doi: 10.7534/j.issn.1009-2137.2013.05.012. Chinese.

PMID:
24156423
4.

Curcumin derivative C817 inhibits proliferation of imatinib-resistant chronic myeloid leukemia cells with wild-type or mutant Bcr-Abl in vitro.

Wu LX, Wu Y, Chen RJ, Liu Y, Huang LS, Lou LG, Zheng ZH, Chen YZ, Xu JH.

Acta Pharmacol Sin. 2014 Mar;35(3):401-9. doi: 10.1038/aps.2013.180. Epub 2014 Feb 3.

5.

[Effect of A Novel Emodin Derivative on Chronic Myelogenous Leukemia K562 Cells and Imatinib-resistant K562/G01 Cells].

Li BJ, Liu TB, Wang WF, Lin MH, Hu JD.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Feb;24(1):1-7. doi: 10.7534/j.issn.1009-2137.2016.01.001. Chinese.

PMID:
26913384
6.

Imatinib (STI571)-mediated changes in glucose metabolism in human leukemia BCR-ABL-positive cells.

Gottschalk S, Anderson N, Hainz C, Eckhardt SG, Serkova NJ.

Clin Cancer Res. 2004 Oct 1;10(19):6661-8.

7.

Guggulsterone of Commiphora mukul resin reverses drug resistance in imatinib-resistant leukemic cells by inhibiting cyclooxygenase-2 and P-glycoprotein.

Xu HB, Xu LZ, Mao XP, Fu J.

Phytomedicine. 2014 Jun 15;21(7):1004-9. doi: 10.1016/j.phymed.2014.02.014. Epub 2014 Mar 26.

PMID:
24680616
8.

[Apoptosis-inducing effect of tetrandrine and imatinib on K562/G01 cells and its related mechanism].

Shi DX, Ma LM, Lu YJ, Bai B.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2014 Jun;22(3):723-8. doi: 10.7534/j.issn.1009-2137.2014.03.028. Chinese.

PMID:
24989284
9.

Effects of POH in combination with STI571 on the proliferation and apoptosis of K562 cells.

Chen Y, Hu D.

J Huazhong Univ Sci Technolog Med Sci. 2004;24(1):41-4.

PMID:
15165112
10.

[Reversal of multidrug-resistance in human leukemia cell line K562/A02 by tyrosine kinase inhibitors].

Shan XY, Chen BA, Xia GH, Xu WL, Ding JH, Gao C, Sun YY, Wang J, Cheng J, Zhao G, Bao W, Song HH, Gao F, Wang F, Wang XM.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2010 Feb;18(1):90-5. Chinese.

PMID:
20137125
11.

Synergistic interactions between DMAG and mitogen-activated protein kinase kinase 1/2 inhibitors in Bcr/abl+ leukemia cells sensitive and resistant to imatinib mesylate.

Nguyen TK, Rahmani M, Gao N, Kramer L, Corbin AS, Druker BJ, Dent P, Grant S.

Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2239-47.

12.

Tetrandrine citrate eliminates imatinib-resistant chronic myeloid leukemia cells in vitro and in vivo by inhibiting Bcr-Abl/β-catenin axis.

Xu XH, Gan YC, Xu GB, Chen T, Zhou H, Tang JF, Gu Y, Xu F, Xie YY, Zhao XY, Xu RZ.

J Zhejiang Univ Sci B. 2012 Nov;13(11):867-74. doi: 10.1631/jzus.B1200021.

13.

Gambogic acid induces apoptosis in imatinib-resistant chronic myeloid leukemia cells via inducing proteasome inhibition and caspase-dependent Bcr-Abl downregulation.

Shi X, Chen X, Li X, Lan X, Zhao C, Liu S, Huang H, Liu N, Liao S, Song W, Zhou P, Wang S, Xu L, Wang X, Dou QP, Liu J.

Clin Cancer Res. 2014 Jan 1;20(1):151-63. doi: 10.1158/1078-0432.CCR-13-1063. Epub 2013 Dec 12.

14.
15.
16.

The antiproliferation effect of berbamine on k562 resistant cells by inhibiting NF-kappaB pathway.

Wei YL, Liang Y, Xu L, Zhao XY.

Anat Rec (Hoboken). 2009 Jul;292(7):945-50. doi: 10.1002/ar.20924.

17.

Effects of imatinib and 5-bromotetrandrine on the reversal of multidrug resistance of the K562/A02 cell line.

Chen BA, Shan XY, Chen J, Xia GH, Xu WL, Schmit M.

Chin J Cancer. 2010 Jun;29(6):591-5.

18.

[Study on the mechanisms of imatinib-resistance of cancer stem-like cells in K562/Vp16 cell line].

Song YP, Fang BJ, Wei XD, Zheng S.

Zhonghua Xue Ye Xue Za Zhi. 2005 Nov;26(11):669-73. Chinese.

PMID:
16620554
19.

Aclacinomycin A sensitizes K562 chronic myeloid leukemia cells to imatinib through p38MAPK-mediated erythroid differentiation.

Lee YL, Chen CW, Liu FH, Huang YW, Huang HM.

PLoS One. 2013 Apr 17;8(4):e61939. doi: 10.1371/journal.pone.0061939. Print 2013. Erratum in: PLoS One. 2017 Oct 11;12 (10 ):e0186528.

20.

Changes associated with the development of resistance to imatinib (STI571) in two leukemia cell lines expressing p210 Bcr/Abl protein.

Scappini B, Gatto S, Onida F, Ricci C, Divoky V, Wierda WG, Andreeff M, Dong L, Hayes K, Verstovsek S, Kantarjian HM, Beran M.

Cancer. 2004 Apr 1;100(7):1459-71.

Supplemental Content

Support Center